| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $626.25M | - | |
| CEO | 296.8K | $7.15M | - | |
| Other | 282.8K | $6.81M | - | |
| Other | 216.6K | $5.22M | - | |
| Dir | 38.2K | $920.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | Schuth Alexander O.75 | Cofo And Secretary | Sale+OE | 3,497 | $30.09 | $105,224.73 | -0.7% | +6.1% | -43.5% | |
| Feb 13, 2023 | Ho Carole73 | Chief Medical Officer | Sell | 3,366 | $30.03 | $101,071.20 | -0.9% | +6.1% | -43.5% | |
| Feb 10, 2023 | Watts Ryan J.77 | President And CEO | Sale+OE | 28,433 | $29.28 | $832,515.47 | -0.6% | -4.9% | -38.0% | |
| Feb 8, 2023 | Krognes Steve E.74 | Director | Sell | 1,377 | $30.88 | $42,521.76 | -0.9% | -10.4% | -43.6% | |
| Feb 8, 2023 | Ho Carole73 | Chief Medical Officer | Sell | 1,521 | $30.88 | $46,968.48 | -0.8% | -10.4% | -43.6% | |
| Feb 8, 2023 | Schuth Alexander O.75 | Cofo And Secretary | Sell | 1,521 | $30.89 | $46,983.69 | -0.3% | -10.4% | -43.6% | |
| Jan 17, 2023 | Schuth Alexander O.75 | Cofo And Secretary | Sale+OE | 10,000 | $29.53 | $295,338.76 | -1.0% | -15.1% | -43.1% | |
| Jan 9, 2023 | Ho Carole73 | Chief Medical Officer | Sell | 1,459 | $28.48 | $41,552.32 | -0.8% | -13.5% | -29.1% | |
| Jan 6, 2023 | Ho Carole73 | Chief Medical Officer | Sell | 4,087 | $28.52 | $116,568.01 | -1.1% | -16.0% | -33.1% | |
| Jan 5, 2023 | Krognes Steve E.74 | Director | Sell | 2,970 | $28.44 | $84,466.80 | -2.0% | -16.1% | -32.7% |